Product NewsABLYNX AND PROCTER & GAMBLE EXTEND NANOBODY™ DRUG DISCOVERY AND DEVELOPMENT AGREEMENT TO METABOLIC TARGETS
Product NewsLe nouvel anticorps monoclonal CD136 (RON)-PE RUO identifie un marqueur potentiel des cellules épithéliales
Product NewsAblynx reveals power of Nanoclone™ - A high throughput method for isolating highly potent antibody-derived therapeutic proteins (Nanobodies™)
Product NewsNew CD136 (RON)-PE RUO Monoclonal Antibody Identifies Potential Marker of Epithelial Cells
Product NewsBeckman Coulter Doubles Capacity of IgY Proteome Enrichment Chemistry for Biomarker Discovery
Product NewsMalignant melanoma identified as disease target for YP004, York Pharma’s skin cancer programme
Product NewsBiométhodes annonce un nouveau succès de Massive Mutagenesis® pour l’optimisation d’anticorps
Product NewsBiométhodes reports a new success in antibody optimisation using Massive Mutagenesis®
Product NewsMorphoSys and Chemicon International Enter into Worldwide Licensing Agreement for Research Antibodies
Product NewsSYMPHOGEN’S SUCCESS IN MANUFACTURING CONSISTENT BATCHES OF POLYCLONAL ANTIBODIES FOR CLINICAL TRIALS ATTRACTS NEW USD 25 MILLION INVESTMENT
